History
  • No items yet
midpage
SANDOVAL v. LIFECELL CORPORATION
2:21-cv-17705
D.N.J.
Dec 3, 2021
Read the full case

Background

  • Three plaintiffs (Sandoval, Braum, Gates) sued LifeCell Corporation, Allergan USA, Inc., and Allergan, Inc. in New Jersey state court alleging defective hernia mesh products; claims were state-law (products liability, negligence, fraud).
  • Defendants removed to federal court asserting diversity jurisdiction (no defendant a citizen of Texas or Michigan; amount in controversy > $75,000).
  • Plaintiffs moved to remand, arguing the forum-defendant rule (28 U.S.C. § 1441(b)(2)) barred removal because defendants’ principal places of business were in New Jersey.
  • Defendants produced a sworn declaration (Weith) and exhibit showing AbbVie’s May 2020 acquisition and that defendants relocated their nerve centers to North Chicago, Illinois, completed by August 1, 2021.
  • Plaintiffs pointed to legacy public-facing materials, Secretary of State filings, and extensive New Jersey operations to challenge the claimed relocation.
  • The magistrate judge applied the Hertz nerve-center test and the preponderance-of-evidence standard, found defendants’ proof sufficient that their principal place of business was in Illinois at removal, and recommended denying remand and fees.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether any defendant was a citizen of New Jersey at removal (forum-defendant rule) Defendants remain citizens of New Jersey because their headquarters, substantial operations, and public filings show NJ as principal place of business Defendants’ officers, corporate books, and key governance moved to North Chicago by Aug 1, 2021; therefore principal place of business is Illinois Defendants met their burden by preponderance; not forum defendants; removal proper
Sufficiency of sworn declaration (Weith) to prove relocation Declaration is too "barebones" and lacks granular operational detail Declaration plus exhibit (California filing) showing officer locations and records moved is competent evidence of nerve center relocation Declaration and supporting filings were sufficient under Hertz and district-court practice
Weight of continuing NJ operations and legacy public filings Ongoing manufacturing, local employees, and public-facing NJ addresses show nerve center remained in NJ Those are legacy or operational sites; nerve-center test focuses on where officers direct, control, coordinate — Illinois Court held operational presence in NJ is immaterial to nerve-center inquiry; legacy filings did not overcome defendants’ proof
Entitlement to attorneys’ fees/costs under 28 U.S.C. § 1447(c) Plaintiffs sought fees after remand motion Defendants opposed fees as removal was proper Court recommended denial of fees because removal was not defective

Key Cases Cited

  • Hertz Corp. v. Friend, 559 U.S. 77 (2010) (establishes the "nerve center" test for a corporation's principal place of business)
  • McCann v. Newman Irrevocable Trust, 458 F.3d 281 (3d Cir. 2006) (preponderance-of-evidence standard for domicile/citizenship changes)
  • Frederico v. Home Depot, 507 F.3d 188 (3d Cir. 2007) (burden of proof on removing party to establish proper removal)
  • Encompass Ins. Co. v. Stone Mansion Restaurant Inc., 902 F.3d 147 (3d Cir. 2018) (forum-defendant rule is procedural, not jurisdictional)
  • McCollum v. State Farm Ins. Co., [citation="376 F. App'x 217"] (3d Cir. 2010) (district courts may rely on sworn affidavits to evaluate corporate citizenship)
  • Wells Fargo Bank, N.A. v. Dey-El, [citation="788 F. App'x 857"] (3d Cir. 2019) (forum-defendant rule is a procedural defect that must be timely raised)
Read the full case

Case Details

Case Name: SANDOVAL v. LIFECELL CORPORATION
Court Name: District Court, D. New Jersey
Date Published: Dec 3, 2021
Docket Number: 2:21-cv-17705
Court Abbreviation: D.N.J.